A nationwide evaluation of off-label drug utilization in Turkey

Ozdamar E. N., AKICI A., Alkan A., Bayar B., Gursoz H.

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.47, sa.4, ss.1229-1238, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 47 Sayı: 4
  • Basım Tarihi: 2017
  • Doi Numarası: 10.3906/sag-1609-129
  • Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.1229-1238
  • Anahtar Kelimeler: Off-label drug use, systemic lupus erythematosus, mycophenolate, rituximab, SYSTEMIC-LUPUS-ERYTHEMATOSUS, MULTIPLE-SCLEROSIS, PULMONARY-HYPERTENSION, HOSPITALIZED CHILDREN, MEDICINE USE, RITUXIMAB, EFFICACY, PRESCRIPTIONS, EPIDEMIOLOGY, ONCOLOGY
  • Marmara Üniversitesi Adresli: Evet

Özet

Background/aim: Off-label drug use (OLDU) is under the control of the Turkish Medicines and Medical Devices Agency (TMMDA) in Turkey. It was aimed to investigate demographic and medical features of patients with OLDU applications in Turkey.